PERSPECTIVE THERAPEUTICS, INC.

CATX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $30.6M $61.6M $9.2M $21.0M $60.4M $2.4M $5.3M $2.6M
Accounts Receivable $6.0K $116.0K $1.2M $1.4M $2.0M $2.0M $1.2M $1.2M
Inventory $1.4M $980.0K $645.0K $530.0K $494.0K
Total Current Assets $148.4M $231.2M $16.8M $53.2M $67.3M $5.5M $7.3M $5.4M
Property, Plant & Equipment $76.6M $57.3M $5.6M $371.0K $2.0M $1.7M $1.6M $1.3M
Goodwill $0 $24.1M $0
Intangible Assets (Excl. Goodwill) $362.0K $279.0K $354.0K $25.0K $130.0K $138.0K $162.0K $198.0K
Total Assets $267.0M $341.1M $97.9M $58.1M $70.4M $8.7M $9.4M $7.5M
Liabilities
Accounts Payable
Total Current Liabilities $28.7M $18.2M $15.7M $3.1M $1.8M $1.6M $1.1M $1.8M
Long-Term Debt $1.6M $1.7M $1.7M
Total Liabilities $59.9M $50.4M $22.7M $3.4M $3.0M $3.0M $1.7M $2.4M
Stockholders' Equity
Retained Earnings $-334.8M $-231.7M $-152.4M $-105.9M $-91.3M $-87.9M $-84.5M $-79.3M
Total Stockholders' Equity $207.0M $290.7M $75.2M $54.6M $67.4M $5.7M $7.7M $5.0M
← Newer Page 1 of 2 Older →
Charlie Munger

People calculate too much and think too little.